New approach methodologies for the biological safety assessment of medical devices

By Jocivania Oliveira da Silva and Marielle Fournier2024-08-13T10:00:00

New approach methodologies (NAMs) are actively being developed to supplement or replace in vivo testing as part of the drive towards the three Rs of replacement, reduction and refinement of animal experiments. This article provides an overview of NAMs and their recent developments in biological safety assessments, with an emphasis on the application to medical devices.

How to read this journal article

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.

1. REGISTER FOR FREE

Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

Create your own library to save your favourite content.

Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

3. JOIN TOPRA

Special offer on TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £230.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career-boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends on 30 September 2024.

Become a member